Which Are the Critical Measures to Assess the Driving Performance of Drivers with Brain Pathologies?  by Pavlou, Dimosthenis et al.
 Transportation Research Procedia  14 ( 2016 )  4393 – 4402 
2352-1465 © 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of Road and Bridge Research Institute (IBDiM)
doi: 10.1016/j.trpro.2016.05.361 
Available online at www.sciencedirect.com
ScienceDirect
6th Transport Research Arena April 18-21, 2016  
Which are the critical measures to assess the driving performance 
of drivers with brain pathologies? 
Dimosthenis Pavlou a,*, Ion Beratis b, Eleonora Papadimitriou a, Constantinos Antoniou a, 
George Yannis a, Sokratis Papageorgiou b 
aDepartment of Transportation Planning and Enginnering, NTUA, 5 Heroon Polytechniou str., GR-15773, Athens, Greece 
b2nd Department of Neurology, “Attikon” University General Hospital, UoA, 75 Mikras Asias str., GR-11527, Athens, Greece 
Abstract 
Driving requires possessing cognitive, motor and visual skills and drivers need to have adequate motor strength, coordination and 
speed. More importantly, cognitive skills including concentration, attention, adequate visual perceptual skills, insight and 
memory must be present. The normal ageing process leads to declines in these motor and cognitive skills, and when combined 
with a brain pathology, it may significantly impair the person's driving performance, especially when unexpected incidents occur. 
The objective of this paper is to identify the critical driving performance measures in which drivers with cognitive impairments 
significantly deviate from the general population, through a driving simulator experiment. The brain pathologies considered 
concern Alzheimer’s disease (AD), Parkinson’s disease (PD) and Mild Cognitive Impairment (MCI). More analytically, a full 
neurological and neuropsychological assessment was carried out at the “ATTIKON” General Hospital in Athens, by neurologists 
and neuropsychologists of the UoA. Then, participants drove at the driving simulator of the NTUA. The driving tasks included 
driving in urban and rural road environment, while various unexpected incidents were scheduled to occur during the drives. The 
driving performance of 109 drivers with cognitive impairments (MCI, AD or PD) was compared to the driving performance of 
31 healthy drivers of similar demographics. For each driver, the following driving performance measures were calculated and 
examined: speed, speed variability, lateral position, lateral position variability, headway, headway variability, and reaction time. 
All these parameters were compared to the range of “typical” values of the respective distribution of healthy drivers, and 
significant deviations from the “typical” distribution were identified. Results indicated that group of patients had various 
difficulties in driving performance compared with the control drivers. More specifically, more than 50% of the patients had 
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extremely low mean speeds, and they often had lower speed variability (in 40% of the cases) than controls. Regarding the lateral 
position, the patients had difficulty in positioning the vehicle in the lane, and more than 1 out of 5 patients had very large 
variability in their lateral position. Also, 44% of the drivers with a brain pathology kept very large mean headways from the 
vehicle ahead. Finally, 50% of patients had very slow reaction times in unexpected incidents; in rural area 70% of the patients 
had reaction times larger than 2 seconds. 
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1. Brain pathologies and driving performance – literature review 
Driving is considered to be a complicated task that requires possessing sufficient cognitive, visual and motor 
skills and drivers must have highly cognitive skills such as speed, coordination, concentration, attention, adequate 
visual and perceptual skills, insight, judgement and memory. More importantly the task of driving requires the 
ability to receive sensory information, process the information, and to make proper, timely judgments and responses 
(Freund et al., 2005). Also, higher cortical functions required for driving include strategic and risk taking behavioral 
skills, including the ability to process multiple simultaneous environmental cues in order to make rapid, accurate and 
safe decisions. The ability for an individual to drive can be affected by various motor, visual, cognitive and 
perceptual deficits which are caused by normal ageing process or are related to neurologic/cerebral disorders. More 
specifically, physical aging, often accompanied by sensory and motor problems, along with some cognitive 
deceleration, may affect negatively someone’s ability to drive efficiently (Ott & Daiello, 2010).  
Diseases affecting a person’s brain functioning (e.g. presence of specific brain pathology due to neurological 
diseases as Alzheimer’s disease, Parkinson’s disease, or Mild Cognitive Impairment, effect of pharmaceutical 
substances used for the treatment of various neurological disturbances) may significantly impair the person's driving 
behavior. These conditions have obvious impacts on driving behavior in mild cases but more importantly in the very 
early stages, they may be imperceptible in one’s daily routine and driving ability. Taking into account that the 
percentage of the elderly in society is increasing (Baldock et al., 2007), while at the same time the level of 
motorization also increases (Yannis et al., 2011), the need to investigate the impact of these conditions on driving 
behaviour becomes quite critical. Drivers who suffer from a brain pathology may have difficulties in their usual 
activities, including driving competence. However, scientists cannot agree to what extend mild cognitive impairment 
is affecting driving behaviour and road safety. The greater the dementia severity is, the greater is the likelihood of 
poor driving ability (Hunt et al. 1993). While it might be assumed that individuals with dementia would stop driving 
after onset of symptoms, it is estimated that around one-third of drivers with dementia continue to drive (Silverstein 
2008). Most drivers are early in the disease process when cognitive deficits are generally mild (Adler & Kuskowski 
2003) and changes to driving performance are minimal. Nonetheless, drivers with dementia are one of the groups 
considered at greatest risk for unsafe driving performance (Langford et al. 2007). Road accidents, while infrequent, 
are also of concern for drivers with dementia, whose crash risk is two to five times that of unimpaired older drivers 
(Charlton et al. 2003). Furthermore, driving skills predictably worsen and will ultimately require individuals with 
dementia to stop driving (Adler et al. 2005). Driving decisions need to be made not on diagnosis but on an 
assessment of the dementia’s progress and the disease’s effects on functional abilities (Duchek et al. 2003, Eby et al. 
2009, Eby & Molnar 2010). Α typical approach to assessing driving skills in individuals with dementia uses 
a driving simulator. Learning to use a simulator, however, can be difficult for drivers with dementia even when 
given time to adapt to the setting (Cox et al. 1998). Owsley et al. (1991) developed the “useful field of view” 
(UFOV) that captures both speed of visual attention and ability to focus visual attention despite distractions. In two 
prospective studies, UFOV was found to predict crashes over a three year time period (Ball et al. 1993, Owsley et al. 
1991) in a sample of older adults. Other cognitive measures, including memory scores, did not further predict 
driving performance. In a recent meta-analysis of the relationship between performance on neuropsychological tests 
and on-road driving ability in patients with dementia and elderly controls, measures of visuospatial abilities were 
more strongly associated with driving than were other cognitive domains (Reger et al. 2004). 
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Overall, international literature indicates that drivers with brain pathologies, namely dementia, AD, MCI or PD, 
may have difficulties in several driving performance indexes. The presence of a brain pathology leads to severe 
deterioration of the driving behaviour, regarding several longitudinal and lateral control measures, and road safety 
control measures such as the reaction time, which can lead to high accident risk (Pavlou et al., 2015). 
2. Objectives 
This paper aims to identify the driving performance measures in which drivers with cognitive impairments 
caused by brain pathologies significantly deviate from the general population. The driving performance of 
109 drivers with cognitive impairments, (59 drivers with Mild Cognitive Impairment (MCI), 25 drivers with 
Alzheimer’s Disease (AD) and 25 drivers with Parkinson’s Disease (PD)), was compared to the driving performance 
of 31 healthy drivers of similar demographics, through a driving simulator experiment. For each driver, the 
following driving performance measures were calculated and examined: a) mean speed, b) mean speed variability, 
c) time headway, d) time headway variability, e) lateral position, f) lateral position variability, and g) reaction time 
at incidents. All these driving indexes were compared to the range of “typical” values of the respective distribution 
of healthy drivers. In particular, we hypothesized that the presence of a brain pathology has a negative effect on the 
driving performance measures of PD, AD and MCI patients as compared to cognitive intact individuals of similar 
age, education and driving experience. Thus, we expected that the group of patients significantly deviate from the 
range of “typical values” of the control group, in most cases.  
3. Methodology 
3.1. Overview of the experiment 
Road safety research often makes use of driving simulators, as they allow for the examination of a range of 
driving performance measures in a controlled, relatively realistic and safe driving environment. Driving simulators, 
however, vary substantially in their characteristics, and this can affect their realism and the validity of the results 
obtained. Despite these limitations, driving simulators are an increasingly popular tool for measuring and analyzing 
driver distraction, and numerous studies have been conducted, particularly in the last decade.This study was carried 
out within the framework of two research projects: DriverBrain and Distract research project. They were carried out 
by an interdisciplinary research team of transportation engineers, neurologists and neuropsychologists (Yannis et al. 
2013, Pavlou et al. 2014). According to the objectives of the analysis, the experiment included three types of 
assessment: a) a neurological assessment which concerned the administration of a full clinical medical, 
ophthalmological and neurological evaluation, in order to well document the characteristics of each of these 
disorders (e.g. MCI, AD, PD, as well as other related parameters of potential impact on driving (i.e. use of 
medication affecting the Central Nervous System), b) a neuropsychological assessment which concerned the 
administration of a series of neuropsychological tests and psychological-behavioural questionnaires to the 
participants. The tests carried out covered a large spectrum of Cognitive Functions: visuospatial and verbal episodic 
and working memory, general selective and divided attention, reaction time, processing speed, psychomotor speed 
etc., and c) a “driving at the simulator assessment”; after clustering our sample scheme in four categories by the 
neuropsychological and the neurological teams (group of PD, group of AD, group of MCI and group of healthy 
controls) all participants moved on to the third type of assessment. The third type of assessment concerned the 
programming of a set of driving tasks into the driving simulator for different driving scenarios. The driving 
simulator experiment took place at the Department of Transportation Planning and Engineering of the National 
Technical University of Athens, where the FOERST Driving Simulator is located. The NTUA driving simulator is 
a motion base quarter-cab manufactured by the FOERST Company. The simulator consists of 3 LCD wide screens 
40'' (full HD: 1920×1080 pixels), driving position and support motion base. The dimensions at a full development 
are 230×180 cm, while the base width is 78 cm and the total field of view is 170 degrees. Research evidence from 
on-road testing supports the validity properties of the driving simulator that was applied in the current study (Yannis 
et al., 2015).  
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3.2. Driving simulator experiment – rural and urban sessions 
The driving simulator experiment began with one practice drive (usually 15–20 minutes), until the participant 
fully familiarized with the simulation environment. Afterwards, all participants continued to the two sessions. Each 
session corresponds to a different road environment (Figure 1): a) rural route that is 2.1 km long, single carriageway 
and the lane width is 3 m, with zero gradient and mild horizontal curves, b) an urban route that is 1.7 km long, at its 
bigger part dual carriageway, separated by guardrails, and the lane width is 3.5 m. Moreover, narrow sidewalks, 
commercial uses and parking are available at the roadsides. During each trial, 2 unexpected incidents were 
scheduled to occur at fixed points along the drive. More specifically, incidents in rural area concerned the sudden 
appearance of an animal (deer or donkey) on the roadway, and incidents in urban areas concerned the sudden 
appearance of an adult pedestrian or of a child chasing a ball on the roadway or of a car suddenly getting out of 
a parking position and getting in the road. Regarding the time point that the hazard appears, it depends on the speed 
and the time to collision in order to have identical conditions for all participants to react, either they drove fast or 
slowly. Thus, there was no possibility for the incident to appear closely or more suddenly to a participant than to 
another.  
 
 
 
 
 
Fig. 1. The two plans of the driving routes (rural and urban) and two screenshots for each driving environment. 
3.3. Ethical issues 
The study was approved by the Ethics Committee of the University General Hospital “ATTIKON”. Informed 
consent was obtained from all individuals studied; it was explained to them that participation was on a voluntary 
basis and that they had the right to withdraw any time they wished to. Participants were informed on the nature of 
the study, the duration of their engagement and the type of information that they would be asked to give.  
4. Participants 
For the purpose of this paper 274 participants have, at least, started the driving simulator experiment that was 
described analytically in the above chapters. 49 participants were eliminated from the study because they had 
simulator sickness issues from the very beginning of the driving simulator experiment. Thus, 225 individuals (both 
patients with cerebral diseases and “healthy controls”) went through the whole experiment procedure. 
25 participants had a brain pathology which was beyond the purpose of this paper and thus, they were eliminated 
from the analyses. Finally, 60 participants were of younger age (<55 years old) and they were eliminated from this 
study too, in order not to have age as a parameter that may affects the results, but only their cerebral condition.  
Summarizing the above, 140 participants of more than 55 years of age went through the whole experimental 
procedure. More specifically, our sample scheme consists of 109 patients with cerebral diseases (69.0 years of age 
on average, 80 males) and 31 healthy controls (64.5 years of age on average, 20 males). The group of patients 
includes 25 AD patients (75.4 years of age on average), 59 MCI patients (70.1 years of age on average) and 25 PD 
patients (66.1 years of age on average). In Table 1, the between-group comparisons in age, driving experience, 
driving exposure (number of days driven per week and kilometers per week), and in the number of years of 
education are presented. The difference in age between the two groups was not statistically significant at the 
0.05 level (p=0.316); the groups were not statistically different in terms of gender, driving experience, frequency of 
driving (number of days and kilometers they drive per week), years of education (Table 1). The similarities in 
demographic characteristics within the participants are significant and the sampling scheme can be safely considered 
to be representative. 
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Table 1. Comparison of patients with brain pathologies and of a Control group without neurological history on various demographics with the use 
of the Wilcoxon Rank Sum Test. 
 Group of patients Control group P-values 
Age, y, mean±SD 69.0±7.4 64.5±7.8 0.316 
Gender, n, M/F 109, 80/29 31, 20/11 1.000 
Driving experience, y, mean±SD  39.8±4.8  35.9±3.7  0.298 
Days/week, median (range) 4 (2-7) 5 (2-7) 0.589 
Education, y, mean±SD  11.9±3.4  14.5±2.4 0.853 
The following inclusion criteria were required for participation in the current study: a) valid driving license, b) 
more than 3 years of driving experience, c) driving more than 2500 km during the last year, d) driving at least 
10 km/week during the last year, e) no history of psychosis, f) absence of any significant kinetic disorder that 
prevents them from basic driving movements, g) absence of dizziness or nausea while driving, either as a driver or 
as a passenger, h) absence of alcohol or any other drug addiction, i) absence of any significant eye disorder that 
prevents them from driving safely. 
5. Results 
The objective of this paper is to identify the driving performance measures in which drivers with cognitive 
impairments significantly deviate from the general population. For that reason, 7 key driving performance measures 
were examined, which correspond to both longitudinal and lateral driving control measures, in rural and urban areas, 
and are presented below: 
x Mean speed – refers to the mean speed of the driver along the route, excluding the small sections in which 
incidents occurred, and excluding junction areas. 
x Mean speed variability – refers to the variability (standard deviation) of the mean speed 
x Time headway – refers to the time space between the simulator vehicle and the vehicle ahead  
x Time headway variability – refers to the variability (standard deviation) of the time headway 
x Lateral position – refers to the distance between the simulator vehicle and the middle of the road 
x Lateral position variability – refers to the variability (standard deviation) of the lateral position of the vehicle 
x Reaction time – refers to the time between the first appearance of the event – “obstacle” on the road and the 
moment the driver starts to brake.  
In Table 2, the between-group comparisons in the 7 key driving performance indexes are presented for rural and 
urban driving environment. There were significant differences between the group of patients and the control group 
in several driving measures, namely mean speed in both driving areas, headway in rural area, and reaction time. 
Overall in seemed that patients with brain pathologies drove at much lower speeds, had less variability in their mean 
speed, they kept larger headways and had significantly worse reaction times than their cognitively intact 
counterparts.  
Table 2. Comparison of patients with brain pathologies and of a Control group without neurological history on the 7 driving measures in rural and 
urban area, with the use of the Wilcoxon Rank Sum Test. 
 Group of patients Control group P-values 
Mean Speed – Rural 36.5±8.0 44.3±7.5 0.010 
Mean Speed – Urban 25.8±5.6 29.7±5.2 0.041 
Mean Speed Variability – Rural 10.3±3.3 12.4±3.3 0.071 
Mean Speed Variability – Urban 10.1±2.7 11.9±2.8 0.113 
Time Headway – Rural 63.9±42.8 39.1±23.6 0.021 
Time Headway – Urban 42.9±21.4 40.6±30.0 0.090 
Time Headway Variability – Rural 179.8±117.1 170.0±102.5 0.113 
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 Group of patients Control group P-values 
Time Headway Variability – Urban 248.7±136.6 249.2±168.8 0.467 
Lateral Position – Rural 1.5±0.2 1.5±0.1 1.000 
Lateral Position – Urban 3.4±0.6 3.1±0.6 0.545 
Lateral Position Variability -Rural 0.3±0.1 0.3±0.1 1.000 
Lateral Position Variability – Urban 1.9±0.5 1.6±0.6 0.189 
Reaction Time – Rural 2207.2±728.8 1644.4±531.5 0.001 
Reaction Time – Urban 1618.2±361.9 1360.6±418.9 0.001 
The two groups had differences in a majority of driving performance measures, but the objective of this study is 
to examine the individual driving performance of each participant with a brain pathology. For that reason, all 7 key 
measures were analyzed by a descriptive statistics technique which is described below: control groups’ mean values 
minus one standard deviation and plus one standard deviation include 68.26% of the values of healthy controls 
(according to the normal distribution). For the purpose of this study, this area is defined by our research team as the 
“typical area” (Figure 2). The individual driving indexes of all participants with cerebral diseases were compared to 
the “typical area” of the control group, in rural and urban driving environment and the results are presented in the 
next sections. 
Fig. 2. Normal distribution – “typical area” of this study: Control groups’ mean values minus one standard deviation and plus one standard 
deviation. 
5.1. Mean speed 
In Figures 3 and 4, the mean speed profiles and the mean speed variability profiles of patients with cerebral 
diseases are compared to the control’s “typical area” (blue box represents the “typical area” in the rural area, 
whereas the brown box represents the “typical area” in the urban area) and several significant results were extracted; 
overall, 51% of the patients had extremely low mean speeds (below the lower limit of the control’s “typical area”). 
Especially the group of AD patients drove significantly slower than the controls at the 68% of the cases. As 
expected, the speed was lower in urban area for all participants. Then, only 6% of the patients with cerebral diseases 
drove too fast, compared to the healthy controls. Regarding the mean speed of the PD and AD group, only the 35% 
of these drivers were inside the “typical area”. Finally, drivers with a brain pathology had significantly lower speed 
variability (43% of the cases) than the group of controls. It is notable that 11% of PD drivers had significantly high 
speed variability in rural area. 
 
Fig. 3. Mean speed profiles of patients with brain pathologies. 
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Fig. 4. Mean speed variability profiles of patients with brain pathologies. 
5.2. Time headway 
In Figures 5 and 6, the time headway and the time headway variability profiles of patients with cerebral diseases 
are compared to the control’s “typical area” (blue box represents the “typical area” in the rural area, whereas the 
brown box represents the “typical area” in the urban area) and several significant results were extracted; 44% of the 
drivers with a brain pathology in rural area have kept very large time headways, but in urban area this percentage 
was significantly lower (12%). No AD or PD patient kept a headway which was below the lower limit of the 
“typical area”. Also, 20% of the patients had very large variability in their time headways whereas 12% of drivers 
with a brain pathology had significantly lower. It is important to mention, though, that regarding the variability of 
time headway in all groups of patients, at least 6 drivers out of 10 were inside the “typical area”. 
 
Fig. 5. Time headway profiles of patients with brain pathologies. 
 
Fig. 6. Time headway variability profiles of patients with brain pathologies. 
5.3. Lateral position 
In Figures 7 and 8, the lateral position and the lateral position variability profiles of patients with cerebral 
diseases are compared to the control’s “typical area” (blue box represents the “typical area” in the rural area, 
whereas the brown box represents the “typical area” in the urban area) and several significant results were extracted; 
32% of patients in urban area drove closer to the right border of the road (positive lateral position values indicate 
longer distance from the central axis of the road). Overall, 40% of drivers with cerebral disease were out of the 
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“typical area”, regarding the lateral position of the vehicle. Also, more than 1 out of 5 patients had very high 
variability in their lateral position. Especially for the group of AD in rural roads, 30% of this particular group had 
extremely high lateral position variability, despite the fact that the lane was narrow in rural area. It is important to 
mention that the rural route was single carriageway and the lane width was 3 m, whereas the urban route was (at its 
bigger part) dual carriageway, and the lane width is 3.5 m. Thus, the positioning of the vehicle cannot be compared 
between the two road environments. Overall, at least 30% of the patients group were outside the “typical area” 
regarding lateral position variability.  
Fig. 7. Lateral position profiles of patients with brain pathologies. 
Fig. 8. Lateral position variability profiles of patients with brain pathologies. 
5.4. Reaction time 
In Figure 9, the reaction time profiles of patients with cerebral diseases are compared to the control’s “typical 
area” (blue box represents the “typical area” in the rural area, whereas the brown box represents the “typical area” in 
the urban area) and several significant results were extracted; the group of patients significantly deviated from the 
reaction time of the control group. More than 50% of participants with a brain pathology in rural area and 26% in 
urban area had significantly larger reaction times than the control group. In rural area 70% of the patients with 
cerebral diseases had reaction times larger than 2 seconds. Especially for the AD and the PD groups, the 42% of 
these participants were above the upper limit of the “typical area” in both rural and urban driving environments. It is 
important to mention that the reaction times of the rural area cannot be compared of the reaction times in urban area 
because all participants drove firstly in rural area and then in urban area for reasons that we presented in chapter 3. 
Finally, no patient was below the lower limit of the “typical area”, regarding the reaction time.  
Fig. 9. Reaction time profiles of patients with brain pathologies. 
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5. Discussion – conclusions 
This paper aimed to identify the driving performance measures in which drivers with brain pathologies 
significantly deviate from the general population. Relatively few studies exist analyzing the effect of a specific 
pathology on driving performance, and even fewer studies comparing different pathologies. The majority of these 
studies indicate serious deterioration in driving performance of drivers with a cerebral disease compared to healthy 
drivers.  
In this research, the driving performance of 109 drivers with cognitive impairments (AD, PD and MCI) was 
compared to the driving performance of 31 cognitively intact healthy individuals with similar demographics, 
through a large driving simulator experiment. For each driver, the following 7 driving performance measures were 
calculated and examined, namely the mean speed, the mean speed variability, the time headway, the time headway 
variability, the lateral position, the lateral position variability, and the reaction time at incidents. All these driving 
indexes were compared to the range of “typical” values of the respective distribution of healthy drivers. The main 
research hypotheses were that a) the presence of a brain pathology has a negative effect on the driving performance 
measures of PD, AD and MCI patients as compared to cognitive intact individuals of similar age, education and 
driving experience, and b) the group of patients significantly deviate from the range of “typical values” of the 
control group, in most cases.  
Summarizing the results, drivers with cerebral diseases were found to drive at lower speeds compared to the 
healthy control group drivers. Especially the group of AD patients drive significantly slower than the controls at the 
68% of the cases. Regarding the mean speed of the PD and AD group, only the 35% of these drivers were inside the 
“typical area”. Moreover, patients had significantly lower speed variability (43% of the cases) than the group of 
controls. As would be expected, this reduced speed had as a result, increased headways, in both rural and urban 
roads. Comparing the 3 groups of patients, it seemed that group of MCI drove slightly faster than the other 2 groups. 
The low mean speed of the group of patients and the low variability of the mean speed, indicates conservative 
driving behaviour and sometimes self-regulation of their driving behaviour caused by the self-awareness of their 
degraded driving performance. We conclude that drivers who significantly deviate from the “typical area” (below 
the lower limit), regarding mean speed, mean time headway and their variabilities, cannot be considered as “safe” 
drivers. This is a very strong indication, though, for degraded driving performance and should be taken into 
consideration combined with other driving performance indexes. Thus, these 4 measures can be considered as 
critical in order to assess driving performance of patients with cerebral diseases but only in combination with the 
following driving performance measures. 
The following driving performance indexes analysed were the lateral control measures and it was observed that 
32% of patients in urban area drove closer to the right border of the road. Overall, 40% of drivers with cerebral 
diseases were out of the “typical area”, regarding the lateral position of the vehicle. Also, more than 25% of patients 
had very large variability in their lateral position (above the upper limit). Especially for the group of AD in rural 
roads, 30% of this particular group had extremely high lateral position variability, despite the fact that the lane was 
narrow in this area. It seems that the more complex is, the driving environment the more the patients have difficulty 
in maintaining the position of the vehicle in the lane. Thus, the variability of the lateral position is considered to be 
a critical driving performance index. 
Analyzing the reaction times of the patients at unexpected incidents, it was observed that participants with brain 
pathologies had significantly longer reaction times in both rural and urban areas in comparison to the control group. 
Compared with each other, drivers with MCI seemed to have slightly better reaction times than the groups of AD 
and PD in most cases. It was impressive that in rural area 70% of the patients with cerebral diseases had reaction 
times larger than 2 seconds, and no patient was below the lower limit of the “typical area”, whereas 42% of 
participants with AD or PD were above the upper limit of the “typical area” in both rural and urban driving 
environments. All these very large reaction times, are findings of great significance if we take into consideration the 
low mean speeds and low variabilities of the mean speeds that the groups of patients had. Hence, the reaction time is 
considered to be a critical driving performance and road safety parameter, in which the majority of the participants 
with cerebral diseases significantly deviated from the cognitively intact participants of similar demographic 
characteristics. The fact that these “not typical” findings that concern reaction time, are combined with “not typical” 
indexes in the other driving performance measures (like this study) is of great significance. 
In conclusion, the take-home message of the current work is that some of the drivers with brain pathologies had 
serious difficulties in their driving performance in comparison with the healthy controls and their driving indexes 
deviated significantly from the “typical area” of the healthy controls. The presence of a brain pathology, such as 
AD, PD and in a lesser extend MCI, seems to lead to severe deterioration of the driving behaviour, regarding several 
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longitudinal and lateral control measures, and road safety control measures such as the reaction time, which can lead 
to high accident probability. The critical measures to assess the driving performance of drivers with cerebral 
diseases are the mean speed (and its variability), the lateral position variability and the reaction time, but more 
importantly the critical measure is the combined assessment of all these parameters, in order to have a driving 
performance profile of each driver with a brain pathology. 
Overall, all these observations that were extracted from the present study could have considerable practical 
importance; they provide quite useful information for the formulation of efficient driving recommendations which 
have the capacity to reduce the accident probability, and thus to reduce road fatalities in a sensitive group of car 
drivers, such that of drivers with MCI, AD or PD. 
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